PolyPid to Report Second Quarter 2025 Financial Results and Operational Highlights on August 13, 2025

Core Viewpoint - PolyPid Ltd. is set to report its second quarter 2025 financial results and operational highlights on August 13, 2025, with a conference call scheduled for 8:30 AM Eastern Time to discuss these results and provide business updates [1]. Company Overview - PolyPid Ltd. is a late-stage biopharma company focused on improving surgical outcomes through its proprietary PLEX technology, which allows for controlled, prolonged-release of therapeutics [4]. - The company is preparing for the New Drug Application (NDA) submission of its lead product candidate, D-PLEX100, aimed at preventing abdominal colorectal surgical site infections, expected in early 2026 [4]. - PolyPid has a diverse pipeline that includes innovative treatments in oncology, obesity, and diabetes [4]. Conference Call Information - The conference call will take place on August 13, 2025, at 8:30 AM Eastern Time, and participants are encouraged to register at least 5 minutes prior to the call [2][3].